发明名称 |
PHARMACEUTICAL FORMULATIONS |
摘要 |
<p>The invention relates to the use of calcium stearate to inhibit or reduce chemical interaction between an active ingredient substance and a carrier in a solid pharmaceutical formulation, wherein the active ingredient substance is susceptible to chemical interaction with the carrier. An inhalable solid pharmaceutical formulation comprising (a) an active ingredient substance susceptible to chemical interaction with lactose, (b) a carrier and (c) calcium stearate is also provided together with uses thereof and methods related thereto.</p> |
申请公布号 |
WO2005004852(A1) |
申请公布日期 |
2005.01.20 |
申请号 |
WO2004EP07669 |
申请日期 |
2004.07.08 |
申请人 |
GLAXO GROUP LIMITED;THOMAS, MARIAN |
发明人 |
THOMAS, MARIAN |
分类号 |
A61K9/00;A61K47/12;A61P11/06;(IPC1-7):A61K9/72;A61K9/14 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|